- Home
- STRW vs DERM Comparison
STRW vs DERM Comparison
Compare STRW & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRW
- DERM
- Stock Information
- Founded
- STRW 2015
- DERM 2014
- Country
- STRW United States
- DERM United States
- Employees
- STRW N/A
- DERM N/A
- Industry
- STRW Real Estate Investment Trusts
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- STRW Real Estate
- DERM Health Care
- Exchange
- STRW Nasdaq
- DERM Nasdaq
- Market Cap
- STRW 119.6M
- DERM 107.4M
- IPO Year
- STRW N/A
- DERM 2021
- Fundamental
- Price
- STRW $11.99
- DERM $6.11
- Analyst Decision
- STRW Strong Buy
- DERM Strong Buy
- Analyst Count
- STRW 4
- DERM 2
- Target Price
- STRW $13.83
- DERM $10.00
- AVG Volume (30 Days)
- STRW 106.7K
- DERM 65.9K
- Earning Date
- STRW 05-13-2025
- DERM 03-26-2025
- Dividend Yield
- STRW 4.70%
- DERM N/A
- EPS Growth
- STRW 46.58
- DERM N/A
- EPS
- STRW 0.57
- DERM N/A
- Revenue
- STRW $117,058,000.00
- DERM $56,134,000.00
- Revenue This Year
- STRW $13.05
- DERM N/A
- Revenue Next Year
- STRW $4.29
- DERM $36.49
- P/E Ratio
- STRW $19.97
- DERM N/A
- Revenue Growth
- STRW 17.29
- DERM N/A
- 52 Week Low
- STRW $7.59
- DERM $3.20
- 52 Week High
- STRW $12.90
- DERM $6.89
- Technical
- Relative Strength Index (RSI)
- STRW 51.19
- DERM 60.90
- Support Level
- STRW $11.36
- DERM $5.51
- Resistance Level
- STRW $12.42
- DERM $6.84
- Average True Range (ATR)
- STRW 0.70
- DERM 0.43
- MACD
- STRW -0.09
- DERM 0.05
- Stochastic Oscillator
- STRW 42.95
- DERM 60.65
About STRW Strawberry Fields REIT Inc.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's portfolio includes eight branded and three authorized generic prescription drugs for dermatological conditions that are marketed in the United States. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.